Drug Shortage Report for CLINDAMYCIN IV INFUSION

Last updated on 2021-04-20 History
Report ID 137153
Drug Identification Number 02408538
Brand name CLINDAMYCIN IV INFUSION
Common or Proper name CLINDAMYCIN IV INFUSION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 18MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 900MG/50ml 10 LIIF
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-04-01
Estimated end date 2021-04-23
Actual end date 2021-04-16
Shortage status Resolved
Updated date 2021-04-20
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-04-20 French Compare
v5 2021-04-20 English Compare
v4 2021-04-12 French Compare
v3 2021-04-12 English Compare
v2 2021-04-08 French Compare
v1 2021-04-08 English Compare